Healthy Transitions in Late Stage Kidney Disease

An Open Label Randomized Controlled Study to Compare the Impact of Patient Centered Nursing Services in Addition to a Nephrologist's Usual Patient Care With Usual Nephrologist's Care in Late Stage Chronic Kidney Disease Patients.

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02085837

Enrollment

130

Registered

2014-03-13

Start date

2013-10-31

Completion date

2016-01-31

Last updated

2017-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease

Brief summary

Improve health and outcome for people with late stage chronic kidney disease by providing patient centered nursing services in addition to a Nephrologist's routine patient care.

Interventions

OTHEREducation

Additional education will be provided by nurses to improve communication and reduce fragmentation of care.

OTHERDaily weight measurement and monitoring

Monitor weight to avoid problems related to hypervolemia.

OTHERUniversal Dietary education

To improve diet and health

OTHERMedication review

Medication will be reviewed by nurses to detect any discrepancies to reduce medication error.

OTHERFocused advanced directive program

Education will be provided to increase awareness and encourage patients to have advanced directive.

OTHERCountdown to fistula program

To reduce the number of patients starting dialysis with catheter in place, comprehensive stepwise intervention will be provided by nurses to ensure arterio-venous (AV) fistula placement in all appropriate patients, with coordinated follow up and failure recovery processes.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Stage 4-5 Chronic Kidney Disease (CKD), defined as estimated glomerular filtration rate (eGFR) between 0-30 ml/minute * 18 years of age or older

Exclusion criteria

* Cognitive impairment that is clinically apparent

Design outcomes

Primary

Measure	Time frame	Description
Hospitalization rate	18 months	Reduction in hospitalization rate in intervention group as compare to control group.

Secondary

Measure	Time frame	Description
Improve hemodialysis access rates	18 months	Percentage of patients with AVF, AVG or catheters
Home dialysis	18 months	Increase choice of home dialysis as modality of treatment

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026